Enterprise Value
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary
- SEEL enterprise value is not available.
Performance
SEEL Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
SEEL Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| 6 m6 months | - | - | - |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
SEEL Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | $9.87 M | |||
| 3 m | 3-month | $10 M | $9.87 M | ||
| 6 m | 6-month | $12 M | $9.87 M | ||
| 1 y | 1-year | $29 M | $9.87 M | ||
| 3 y | 3-year | $213 M | $9.87 M | ||
| 5 y | 5-year | $464 M | $5.86 M | ||
| alltime | all time | $464 M | -$36 M |
Seelos Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $9.96 M(-59.9%) |
| 2023 | $24.84 M(-67.9%) |
| 2022 | $77.44 M(-31.1%) |
| 2021 | $112.35 M(+40.1%) |
| 2020 | $80.22 M(+211.4%) |
| 2019 | $25.76 M(+3125.4%) |
| 2018 | $798.60 K(-94.6%) |
| 2017 | $14.87 M(-23.9%) |
| 2016 | $19.54 M(+254.4%) |
| 2015 | $5.51 M(-183.3%) |
| 2014 | -$6.62 M(-64.8%) |
| 2013 | -$18.80 M(+60.5%) |
| Date | Value |
|---|---|
| 2012 | -$11.72 M(+241.1%) |
| 2011 | -$3.44 M(-25.5%) |
| 2010 | -$4.61 M(-131.2%) |
| 2009 | $14.78 M(+708.9%) |
| 2008 | $1.83 M(-1026.5%) |
| 2007 | -$197.20 K(-96.8%) |
| 2006 | -$6.20 M(-285.8%) |
| 2005 | $3.34 M(-483.6%) |
| 2004 | -$869.40 K(-67.8%) |
| 2003 | -$2.70 M(-154.0%) |
| 2002 | $5.01 M(-142.1%) |
| 2001 | -$11.90 M(-57.0%) |
| 2000 | -$27.70 M |
FAQ
- What is the all time high enterprise value for Seelos Therapeutics?
What is the all time high enterprise value for Seelos Therapeutics?
Seelos Therapeutics all-time high enterprise value is $464.44 M